Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects

You may not be if

• Active guttate, erythrodermic, or pustular psoriasis at the time of the screening visit
• Pregnant or breast-feeding females
• Evidence of skin conditions at the time of the screening visit (e.g., eczema) that would interfere with evaluations of the effect of the investigational product on psoriasis